Skip to main content
. 2013 Feb 20;8(2):e57114. doi: 10.1371/journal.pone.0057114

Figure 5. Phenotypic analyses of Lin−/lowHLA-DRCD11b+CD33+ MDSCs in colorectal carcer patients.

Figure 5

The expression of putative MDSCs markers, markers of mature and immature myeloid cells, and markers associated with immune regulation was evaluated relative to isotype control (gray histograms).